Clinical trials in acute severe asthma: are type II errors important?
Open Access
- 1 November 1986
- Vol. 41 (11), 824-829
- https://doi.org/10.1136/thx.41.11.824
Abstract
Many studies in acute severe asthma have had low power. Fifteen randomised double blind studies investigating the treatment of acute severe asthma published during 1974-84 were analysed for power and 95% confidence limits. Twelve studies failed to detect a significant difference in bronchodilatation produced by two treatments and reported the treatments to produce equal effect. Each study had, however, less than a 60% probability of detecting a true 25% difference in bronchodilatation.This publication has 25 references indexed in Scilit:
- Glucocorticoids in acute asthmaAmerican Journal Of Medicine, 1983
- Are corticosteroids necessary in the treatment of severe acute asthma?Respiratory Medicine, 1982
- Statistics and ethics in medical research: III How large a sample?BMJ, 1980
- Corticosteroids in status asthmaticusThe Journal of Pediatrics, 1980
- Aminophylline, salbutamol and combined intravenous infusions in acute severe asthmaRespiratory Medicine, 1980
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978
- Intravenous infusion of salbutamol in severe acute asthma.BMJ, 1978
- Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma.BMJ, 1978
- Comparison of intravenous and aerosol salbutamol.BMJ, 1976
- Asthma deaths in Cardiff 1963-74: 53 deaths in hospital.BMJ, 1976